13F-HR/A filed by CAXTON CORP
CAXTON CORP filed this 13F-HR/A for the quarter ended 2020-06-30, filed 2020-08-14, with 15 holding rows worth $94,742,000.
- Accession
- 0000919574-20-005396
- Filer
- CIK 1388551
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, amendment of type restatement, 15 entries on the cover page, a total value of $94,742,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $94,742,000 with VALUE read as thousands by filing date, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MOLECULAR TEMPLATES INC | 608550109 | COM | 2,107,991 | $29,069,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 6,612,065 | $24,994,000 | thousands by filing date | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 1,595,164 | $7,992,000 | thousands by filing date | |
| SIERRA ONCOLOGY INC | 82640U404 | CMN | 643,959 | $7,792,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 620,289 | $6,519,000 | thousands by filing date | |
| SCYNEXIS INC COM NEW | 811292101 | Common Stock | 7,946,111 | $5,967,000 | thousands by filing date | |
| GARRISON CAP INC | 366554103 | COM | 1,164,061 | $3,935,000 | thousands by filing date | |
| SPDR GOLD TR | 78463V107 | GOLD SHS | 15,923 | $2,665,000 | thousands by filing date | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 68,172 | $1,961,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 295,560 | $1,221,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 81,983 | $787,000 | thousands by filing date | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 619,460 | $719,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 124,771 | $636,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 20,406 | $333,000 | thousands by filing date | |
| ADDEX THERAPEUTICS LTD | 00654J107 | SPONSORED ADS | 17,418 | $152,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-20-005228 | superseded | 2020-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000919574-20-005396 | this filing | 2020-08-14 | acceptance time not in the bulk data set |